+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years - 75Years
All Genders
ID06418113

Pilot Study on Safety and Effectiveness of Pre-surgery Radiochemotherapy for Glioblastoma in Adults Aged 18 to 75

Led by Hospital San Carlos, Madrid · Updated on 2024-05-16

12

Participants Needed

1

Research Sites

17 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating the safety and effectiveness of neoadjuvant radiochemotherapy in the surgical treatment of glioblastoma GBM, a type of brain cancer. This pilot study aims primarily to assess safety, focusing on neurological problems, tissue damage, swelling, headaches, wound healing issues, infections, and cerebrospinal fluid leaks. Secondary goals include evaluating progression-free survival, overall survival, cognitive function using the MoCA scale, and quality of life through various assessment tools. The study involves a small group of patients compared to controls, with a two-year follow-up period and ongoing safety monitoring. Participants in the experimental group will first have a stereotactic biopsy to confirm diagnosis. If diagnosed with wildtype IDH non-mutated glioblastoma, they will receive conformal hypofractionated stereotactic radiotherapy targeting tumor regions in 15 sessions over three weeks, combined with daily temozolomide during radiation. Five weeks after radiation, patients undergo guided surgical tumor removal using 5-ALA with neurophysiological monitoring. Starting four weeks after surgery, maintenance temozolomide chemotherapy is given for six months. The control group follows the standard Stupp protocol involving combined radiotherapy and temozolomide chemotherapy. Participants will have monthly clinical follow-ups for two years, including physical and neurological exams, blood tests, and brain imaging every three to six months to monitor safety outcomes. Cognitive function and quality of life will be assessed quarterly over this period. Researchers will study tissue samples from surgeries for additional biological analysis. The study is randomized without masking and aims to provide detailed safety and efficacy data to inform future treatment approaches.

CONDITIONS

Brief Title

Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma

Research Team

J

Juan Antonio Barcia

M

Mª Rebeca Lliguin León

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here